Background: Inflammation is a part of the first line of defense of the body against invasive
pathogens, and plays a crucial role in tissue regeneration and repair. A proper inflammatory …

Acetylcholinesterase (AChE) inhibitors are widely used for the symptomatic treatment of
Alzheimer's disease and other dementias. More recent use is for myasthenia gravis. Many of …

Over the past three decades, there has been constant postulation regarding the infectious
etiology of Alzheimer disease (AD), which in turn suggests the vital role of various infectious …

Introduction Over three years have passed since the emergence of coronavirus disease
2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome …

Donepezil is a reversible and noncompetitive cholinesterase inhibitor. The drug is
considered as a first-line treatment in patients with mild to moderate Alzheimer's disease …

We sought a new approach to treating infections by intracellular bacteria, namely, by altering
host cell functions that support their growth. We screened a library of 640 Food and Drug …

1-Methyl-4-phenylpyridinium (MPP+) induces microglial activation and degeneration of
dopaminergic (DAergic) neurons. Donepezil is a well-known acetylcholinesterase inhibitor …

Donepezil hydrochloride is an acetylcholine esterase inhibitor studied and approved to treat
Alzheimer's disease (AD). However, this drug can have positive therapeutic potential in …

The genetic, cellular, and molecular changes associated with Alzheimer disease provide
evidence of immune and inflammatory processes involvement in its pathogenesis. These …

Ginkgo biloba special extract EGb 761 and donepezil are drugs used in Alzheimer therapy.
The influence of donepezil and EGb 761 on two mechanisms of innate immunity, natural …